A preclinical study using recombinant anti-folate receptor-beta immunotoxin for the treatment of rheumatoid arthritis

重组抗叶酸受体-β免疫毒素治疗类风湿性关节炎的临床前研究

基本信息

  • 批准号:
    17591051
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

OBJECTIVE: To investigate the effects of the recombinant immunotoxin dsFv anti-folate receptor beta (FRβ) on the activation and proliferation of the cell that function in inflammatory and degradative processes in rheumatoid arthritis synovial tissue.20051) Productior of recombinant type anti-human FRβ immunotoxin: The Ig VH-PE38 fusion protein and the Ig VL protein were produced in Escherichia coli, and then joined with a disulfide bond by engineering cysteine residues in the framework regions of these proteins.2) In vitro study: The immunotoxin significantly induced the apoptosis of FRβ-transfected macrophages and adherent RA synovial mononuclear cells.3) In vivo study: Administration of immunotoxin reduced the numbers of CD68^+ macrophages, activated fibroblast-like cells (VCAM-1^+, Angiopoietin-1^+), inflammatory cytokines (TNF-α, IL-6), angiogenesis (CD34^+ cells) in RA synovial tissue engrafted into SCID mice.20061) Tissue localization of FRβ in rhesus monkey: The liver and skin weakly expressed FRβ in rhesus monkey.2) Productior of rat-anti mouse FRβ monoclonal antibody: Murine FRβ cDNA was transfected into rat mastcytorra, and injected into foot-pad of WKY rats. Nine monoclonal antibodies were obtained. Any monoclonal antibodies were not cross-reacted with mouse FRα.3) Tissue localization of FRβ in mouse: FRβ were expressed in thioglycolate-induced peritoneal macrophages (++++), liver (+ 〜 ++), lung (+ 〜 ++) and colon (+), suggesting that inflammatory stimulation may up-regulate; FRβ^+ cells in mouse and rhesus monkey.Conclusion: Immunotoxin would be a promising tool for the treatment of RA. Prospects: Now, investigators are producing anti-mouse FRβ immunotoxin and will examine the effects on murine arthritis model (CIIA-induced arthritis and serum transfer-induced arthritis).
目的:探讨重组免疫毒素dsFv抗叶酸受体β(FRβ)对类风湿性关节炎滑膜组织炎症和降解过程中细胞活化和增殖的影响。20051)重组型抗人FRβ免疫毒素的产生:Ig VH-PE38融合蛋白和Ig VL 蛋白质是在大肠杆菌中产生的,然后通过在这些蛋白质的框架区改造半胱氨酸残基来连接二硫键。2) 体外研究:免疫毒素显着诱导 FRβ 转染的巨噬细胞和贴壁 RA 滑膜单核细胞的凋亡。3) 体内研究:免疫毒素的施用减少了 移植到 SCID 小鼠的 RA 滑膜组织中的 CD68^+ 巨噬细胞、活化的成纤维细胞样细胞(VCAM-1^+、Angiopoietin-1^+)、炎症细胞因子(TNF-α、IL-6)、血管生成(CD34^+ 细胞)。20061) 恒河猴中 FRβ 的组织定位:肝脏和皮肤中 FRβ 弱表达 2)大鼠抗小鼠FRβ单克隆抗体的制备:将鼠FRβcDNA转染大鼠肥大细胞,注射至WKY大鼠足垫。获得了九种单克隆抗体。任何单克隆抗体均不与小鼠FRα发生交叉反应。3)FRβ在小鼠体内的组织定位:FRβ在巯基乙酸诱导的腹腔巨噬细胞(++++)、肝脏(+〜++)、肺(+〜++)和结肠(+)中表达,提示炎症刺激可能上调;小鼠和恒河猴中的FRβ^+细胞。结论:免疫毒素将是治疗RA的有前途的工具。前景:现在,研究人员正在生产抗小鼠FRβ免疫毒素,并将检查其对小鼠关节炎模型(CIIA诱导的关节炎和血清转移诱导的关节炎)的影响。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effectiveness of Anti-Folate Receptor β Antibody Conjugated With Truncated Pseudomonas Exotoxin in the Targeting of Rhematoid Arthritis Synovial Macrophages
抗叶酸受体 β 抗体与截短假单胞菌外毒素缀合在类风湿性关节炎滑膜巨噬细胞靶向中的有效性
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Li S-M.;Li G-M.;Nakamura S.;Ikuta K.;Nakaya T.;Nagayoshi R et al.
  • 通讯作者:
    Nagayoshi R et al.
In vitro and in vivo efficacy of a recombinant immunotoxin against folate receptor beta on the activation and proliferation of rheumatoid arthritis synovial cells.
针对叶酸受体β的重组免疫毒素对类风湿性关节炎滑膜细胞活化和增殖的体外和体内功效。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nagai T;Tanaka M;Tsuneyoshi Y;Matsushita K;Sunahara N;Matsuda T;Yoshida H;Komiya S;Onda M;Matsuyama T.
  • 通讯作者:
    Matsuyama T.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MATSUYAMA Takami其他文献

MATSUYAMA Takami的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MATSUYAMA Takami', 18)}}的其他基金

Therapy targeting folate receptor beta expressing macrophages in chronic inflammation
针对慢性炎症中表达叶酸受体β的巨噬细胞的治疗
  • 批准号:
    23591441
  • 财政年份:
    2011
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The diagnostic and pathological significance of soluble CD163 in rheumatoid arthritis
可溶性CD163在类风湿性关节炎中的诊断及病理意义
  • 批准号:
    13670464
  • 财政年份:
    2001
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibitory effects of membraneous beparin binding EGF like Factor on the apoptosis.
膜质beparin结合EGF样因子对细胞凋亡的抑制作用。
  • 批准号:
    11670453
  • 财政年份:
    1999
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of the anergy of T cells induced by varient types of soluble VCAM-1
不同类型可溶性VCAM-1诱导T细胞无反应性的机制
  • 批准号:
    09670483
  • 财政年份:
    1997
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of VLA proteins and fibronectin in the activation of synovial cells from rheumatoid arthritis.
VLA 蛋白和纤连蛋白在类风湿性关节炎滑膜细胞激活中的作用。
  • 批准号:
    03670333
  • 财政年份:
    1992
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
To investigate mechanisms and a role of folate receptor induction in tumor development
研究叶酸受体诱导在肿瘤发展中的机制和作用
  • 批准号:
    22K07216
  • 财政年份:
    2022
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation regarding the progress of therapeutic effect of BNCT using folate receptor-targeted boron compound which be administered by convection enhanced delivery
叶酸受体靶向硼化合物对流增强给药BNCT治疗效果研究进展
  • 批准号:
    20K09399
  • 财政年份:
    2020
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
新規子宮体癌治療としてのFolate Receptor α標的治療の開発
开发叶酸受体α靶向疗法作为子宫内膜癌的新疗法
  • 批准号:
    19K23886
  • 财政年份:
    2019
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Analysis of the interaction between the folate receptor beta expression macrophages and cancer stem cells in pancreatic cancer invasion
叶酸受体β表达巨噬细胞与肿瘤干细胞在胰腺癌侵袭中的相互作用分析
  • 批准号:
    25293288
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport
具有选择性叶酸受体肿瘤转运的嘌呤合成抑制剂
  • 批准号:
    8437899
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport
具有选择性叶酸受体肿瘤转运的嘌呤合成抑制剂
  • 批准号:
    8613474
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport
具有选择性叶酸受体肿瘤转运的嘌呤合成抑制剂
  • 批准号:
    8810225
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
Serum folate receptor alpha as a biomarker for epithelial ovarian cancer
血清叶酸受体α作为上皮性卵巢癌的生物标志物
  • 批准号:
    25861504
  • 财政年份:
    2013
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了